ELF4 and neoplasm: Correspondingly, we observed that the disease-free survival (DFS) periods were significantly shorter (log-rank test; p = 1.07 x 10−07) for the patients with high-ELF4 tumours than they were for the patients with low-ELF4 tumours (Fig 1B).